CELLECT

CELLECT Laboratories is a Canadian health technology company developing a non‑invasive diagnostic platform for women’s health using menstrual fluid as a biological sample. Its proprietary nanomaterial captures and stabilizes high‑quality DNA and cells, enabling standard lab tests for cervical cancer, STIs, and other gynecological conditions without invasive procedures or clinic visits. By integrating seamlessly with existing laboratory workflows, CELLECT aims to increase screening participation, enable earlier detection, and expand access to patient‑centered diagnostics globally.